PMC4135132_01
The pathological examination of the biopsy showed undifferentiated carcinoma (H&E x400).
CRIOG2014-798948.001.jpg
PMC4135132_01_CRIOG2014-798948.001.jpg
fig1
A cervical biopsy was performed and the pathological examination of the biopsy showed undifferentiated carcinoma (Figure 1).
MRI (T2-weighted) reveals a large mass infiltrating to the uterine corpus and vagina.
CRIOG2014-798948.002.jpg
PMC4135132_01_CRIOG2014-798948.002.jpg
fig2
Magnetic resonance imaging (MRI) of the pelvis revealed a large mass infiltrating to the uterine corpus and vagina (Figure 2).
(a) CT showing probable spleen metastasis. (b) The mass found in the spleen enlarged.
CRIOG2014-798948.003.jpg
PMC4135132_01_CRIOG2014-798948.003.jpg
fig3
Although five courses of nedaplatin (70 mg/m2/4 weeks) were administered, the level of SCC was elevated to 19.45 ng/dL and the mass in the spleen enlarged (Figure 3).
The surgical specimen of splenectomy.
CRIOG2014-798948.004.jpg
PMC4135132_01_CRIOG2014-798948.004.jpg
fig4
An exploratory laparotomy was performed and the spleen was removed (Figure 4).
The pathological examination revealed undifferentiated carcinoma identical to the former specimen (H&E x400).
CRIOG2014-798948.005.jpg
PMC4135132_01_CRIOG2014-798948.005.jpg
fig5
The result of pathological examination was compatible with metastasis from cervical cancer (Figure 5).